AMGEN S.A. secures contract for Pharmaceutical products - Framework Agreement for the Supply of Medicines without competition for the Hospitals of the Cantabrian Health Service (Active ingredients Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetide hydrochloride, Evolocumab, Inebilizumab, panitumumab)

Spain, Sept. 28 -- Spain based AMGEN S.A. has secured contract from Servicio Cantabro de Salud for Pharmaceutical products - Framework Agreement for the Supply of Medicines without competition for the Hospitals of the Cantabrian Health Service (Active ingredients Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetide hydrochloride, Evolocumab, Inebilizumab, panitumumab) . The value of the contract is worth 2307700 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....